The US Court of Appeals for the Federal Circuit upheld a district court’s findings of invalidity and noninfringement in a Hatch-Waxman case involving two sets of method patents directed to modulating ...

PINE BROOK, N.J.--(BUSINESS WIRE)--Alvogen subsidiary, Lotus Pharmaceuticals (“Lotus”), today announced that Celgene filed a suit on 6 September 2017 in the United States District Court for the ...

In a Hatch-Waxman case, the District of Delaware denied a motion for summary judgment seeking to apply the ANDA filing date as the date of the hypothetical negotiation used to calculate reasonable ...

HERTFORDSHIRE, England, and PITTSBURGH, Feb. 19, 2016 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced that its abbreviated new drug application (ANDA) for fluticasone propionate 100, ...

SUNRISE, Fla., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Transpire Bio, an integrated clinical-stage biopharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, ...

The alternative text for this image may have been generated using AI. The US Federal Circuit Appeals Court has overturned a district court's award of attorney fees to GlaxoSmithKline (GSK) in their ...

LEXINGTON, Mass. - Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that it has received a Paragraph IV Certification Notice Letter from Teva Parenteral Medicines, Inc. (TPM) notifying ...

On Thursday, April 27th, legal data analytics firm Lex Machina released a Hatch-Waxman/ANDA litigation report detailing trends and key findings from pharmaceutical cases filed in U.S. district courts ...

PALO ALTO, Calif., Oct. 5 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) today announced that the website of the US Food and Drug Administration ...

NATCO Pharma Ltd.’s shares rose by 2 per cent after the company announced the submission of an abbreviated new drug application (ANDA) to the US Food and Drug Administration (FDA) for the generic ...